Literature DB >> 11847158

Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval.

M Malik1, P Färbom, V Batchvarov, K Hnatkova, A J Camm.   

Abstract

OBJECTIVE: To compare the QT/RR relation in healthy subjects in order to investigate the differences in optimum heart rate correction of the QT interval.
METHODS: 50 healthy volunteers (25 women, mean age 33.6 (9.5) years, range 19-59 years) took part. Each subject underwent serial 12 lead electrocardiographic monitoring over 24 hours with a 10 second ECG obtained every two minutes. QT intervals and heart rates were measured automatically. In each subject, the QT/RR relation was modelled using six generic regressions, including a linear model (QT = beta + alpha x RR), a hyperbolic model (QT = beta + alpha/RR), and a parabolic model (QT = beta x RR(alpha)). For each model, the parallelism and identity of the regression lines in separate subjects were statistically tested.
RESULTS: The patterns of the QT/RR relation were very different among subjects. Regardless of the generic form of the regression model, highly significant differences were found not only between the regression lines but also between their slopes. For instance, with the linear model, the individual slope (parameter alpha) of any subject differed highly significantly (p < 0.000001) from the linear slope of no fewer than 21 (median 32) other subjects. The linear regression line of 20 subjects differed significantly (p < 0.000001) from the linear regression lines of each other subject. Conversion of the QT/RR regressions to QTc heart rate correction also showed substantial intersubject differences. Optimisation of the formula QTc = QT/RR(alpha) led to individual values of alpha ranging from 0.234 to 0.486.
CONCLUSION: The QT/RR relation exhibits a very substantial intersubject variability in healthy volunteers. The hypothesis underlying each prospective heart rate correction formula that a "physiological" QT/RR relation exists that can be mathematically described and applied to all people is incorrect. Any general heart rate correction formula can be used only for very approximate clinical assessment of the QTc interval over a narrow window of resting heart rates. For detailed precise studies of the QTc interval (for example, drug induced QT interval prolongation), the individual QT/RR relation has to be taken into account.

Entities:  

Mesh:

Year:  2002        PMID: 11847158      PMCID: PMC1767037          DOI: 10.1136/heart.87.3.220

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  38 in total

1.  The normal Q-T interval.

Authors:  E SIMONSON; L D CADY; M WOODBURY
Journal:  Am Heart J       Date:  1962-06       Impact factor: 4.749

2.  Evaluation of five QT correction formulas using a software-assisted method of continuous QT measurement from 24-hour Holter recordings.

Authors:  J Molnar; J Weiss; F Zhang; J E Rosenthal
Journal:  Am J Cardiol       Date:  1996-10-15       Impact factor: 2.778

3.  Computerised measurements of QT dispersion in healthy subjects.

Authors:  Y Gang; X H Guo; R Crook; K Hnatkova; A J Camm; M Malik
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

4.  Outward membrane currents activated in the plateau range of potentials in cardiac Purkinje fibres.

Authors:  D Noble; R W Tsien
Journal:  J Physiol       Date:  1969-01       Impact factor: 5.182

5.  Exponential correction of QT interval to minimize the effect of the heart rate in children.

Authors:  M Yoshinaga; T Tomari; S Aihoshi; T Kawashita; J Nishi; Y Tanaka; T Takezaki; Y Kono; Y Yuasa; M Nakamura
Journal:  Jpn Circ J       Date:  1993-02

6.  Variability of the QTc interval: impact on defining drug effect and low-frequency cardiac event.

Authors:  J Morganroth; A M Brown; S Critz; W J Crumb; D L Kunze; A E Lacerda; H Lopez
Journal:  Am J Cardiol       Date:  1993-08-26       Impact factor: 2.778

7.  Sex differences in the evolution of the electrocardiographic QT interval with age.

Authors:  P M Rautaharju; S H Zhou; S Wong; H P Calhoun; G S Berenson; R Prineas; A Davignon
Journal:  Can J Cardiol       Date:  1992-09       Impact factor: 5.223

8.  Low penetrance in the long-QT syndrome: clinical impact.

Authors:  S G Priori; C Napolitano; P J Schwartz
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

9.  An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)

Authors:  A Sagie; M G Larson; R J Goldberg; J R Bengtson; D Levy
Journal:  Am J Cardiol       Date:  1992-09-15       Impact factor: 2.778

10.  Normal values for QT intervals in ECG during ramp exercise on bicycle.

Authors:  B Wohlfart; O Pahlm
Journal:  Clin Physiol       Date:  1994-07
View more
  107 in total

1.  ISHNE guidelines for electrocardiographic evaluation of drug-related QT prolongation and other alterations in ventricular repolarization: task force summary. A report of the Task Force of the International Society for Holter and Noninvasive Electrocardiology (ISHNE), Committee on Ventricular Repolarization.

Authors:  A J Moss; W Zareba; J Benhorin; J P Couderc; H Kennedy; E Locati-Heilbron; P Maison-Blanche
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-10       Impact factor: 1.468

2.  More light on QT interval measurement.

Authors:  L Toivonen
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

3.  Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval.

Authors:  Marek Malik
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

4.  Prulifloxacin ECG study.

Authors:  Maria Teresa Rosignoli; Paolo Dionisio
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

5.  Dynamics and rate-dependence of the spatial angle between ventricular depolarization and repolarization wave fronts during exercise ECG.

Authors:  Tuomas Kenttä; Mari Karsikas; Antti Kiviniemi; Mikko Tulppo; Tapio Seppänen; Heikki V Huikuri
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

Review 6.  Drug-induced long QT syndrome.

Authors:  Prince Kannankeril; Dan M Roden; Dawood Darbar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 7.  Categorization and theoretical comparison of quantitative methods for assessing QT/RR hysteresis.

Authors:  Hugo Gravel; Daniel Curnier; Nagib Dahdah; Vincent Jacquemet
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05-16       Impact factor: 1.468

8.  Recovery of heart rate variability and ventricular repolarization indices following exercise.

Authors:  Marc K Lahiri; Alexandru Chicos; Dan Bergner; Jason Ng; Smirti Banthia; Norman C Wang; Haris Subačius; Alan H Kadish; Jeffrey J Goldberger
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-08-13       Impact factor: 1.468

Review 9.  Drug-induced torsades de pointes and implications for drug development.

Authors:  Robert R Fenichel; Marek Malik; Charles Antzelevitch; Michael Sanguinetti; Dan M Roden; Silvia G Priori; Jeremy N Ruskin; Raymond J Lipicky; Louis R Cantilena
Journal:  J Cardiovasc Electrophysiol       Date:  2004-04

10.  Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects.

Authors:  P Chaikin; M S Gillen; M Malik; H Pentikis; G R Rhodes; D J Roberts
Journal:  Br J Clin Pharmacol       Date:  2005-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.